Pfizer, Inc. Common Stock — Earnings

Past earnings

1. Tue · Aug 4EPS beat+1.5%on the day
   EPS $0.77 vs est $0.682Revenue $15.0B

   EPS of $0.77 beat the $0.682 estimate (+13%); revenue came in at $15.0B (+4% vs est). Shares rose 1.5% on the release day.

2. Tue · May 5EPS beat+0.6%on the day
   EPS $0.75 vs est $0.722Revenue $14.5B

   EPS of $0.75 beat the $0.722 estimate (+4%); revenue came in at $14.5B (+4% vs est). Shares rose 0.6% on the release day.

3. Tue · Feb 3EPS beat-3.3%on the day
   EPS $0.66 vs est $0.567Revenue $17.6B

   EPS of $0.66 beat the $0.567 estimate (+16%); revenue came in at $17.6B (+4% vs est). Shares fell 3.3% on the release day.

4. Tue · Nov 4EPS beat-1.5%on the day
   EPS $0.87 vs est $0.633Revenue $16.7B

   EPS of $0.87 beat the $0.633 estimate (+37%); revenue came in at $16.7B (+1% vs est). Shares fell 1.5% on the release day.

5. Tue · Aug 5EPS beat+5.2%on the day
   EPS $0.78 vs est $0.58Revenue $14.7B

   EPS of $0.78 beat the $0.58 estimate (+34%); revenue came in at $14.7B (+8% vs est). Shares rose 5.2% on the release day.

On the AI radar now

Live market issues involving PFE

• 1J&J Wins Talc Lawsuit, Clears Key Cancer-Liability OverhangCourt rules talc did not cause cancer in three plaintiffs›
• 5Pfizer Rebounds After Oncology Drug Miss and CFO DeparturePFE stabilizes on yield appeal despite pipeline and mgmt uncertainty›

PFE related news

• Eli Lilly, Regeneron Among First Seven in FDA's Manufacturing PreCheck Pilot — the Supply Chain Acceleration Markets Are UnderpricingTue · Jun 30
• Sanofi (SNY) Leadership Update Draws BofA Optimism: What Pharma Investors Should TrackSun · Jun 28
• US Tariff Probe Into Germany Drug Pricing: What It Means for PFE, MRK, LLY Pharma StocksFri · Jun 19
• Biotech IPO Window Reopens, But Big Pharma M&A Still Drives Deals on Patent-Cliff PressureTue · Jun 16